Press release
Global Nucleic Acid Amplification Testing Market Forecast 2025-2032: 8.13% CAGR Fueled by R&D and Diagnostics Innovation, estimates DelveInsight
Global Nucleic Acid Amplification Testing Market
DelveInsight's report titled "Nucleic Acid Amplification Testing Market Insights, Competitive Landscape and Market Forecast - 2032" offers a detailed assessment of the current and projected market scenario. The study highlights upcoming technological advancements, key growth drivers, challenges, and barriers influencing the market. It also provides insights into emerging diagnostic products and profiles major companies actively engaged in the Nucleic Acid Amplification Testing space.
To understand why North America continues to dominate the NAAT market, explore a snapshot of the Nucleic Acid Amplification Testing Market Trends report - https://www.delveinsight.com/sample-request/nucleic-acid-amplification-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Nucleic Acid Amplification Testing Overview
Nucleic Acid Amplification Testing (NAAT) is an advanced molecular diagnostic approach designed to detect and amplify DNA or RNA from disease-causing organisms such as viruses and bacteria. Its ability to identify minimal quantities of genetic material enables early and highly accurate diagnosis of infectious diseases, including HIV, COVID-19, tuberculosis, and sexually transmitted infections. NAAT encompasses methodologies such as Polymerase Chain Reaction (PCR) and Transcription-Mediated Amplification (TMA). Renowned for its high sensitivity, rapid turnaround, and diagnostic accuracy, NAAT has become an essential tool in clinical diagnostics, public health surveillance, and disease control programs.
DelveInsight Analysis
DelveInsight estimates that the global Nucleic Acid Amplification Testing (NAAT) market is expected to grow at a compound annual growth rate (CAGR) of 8.13% during the forecast period spanning 2025 to 2032.
Nucleic Acid Amplification Testing Market Insights
From a regional perspective, North America accounted for the largest share of the NAAT market, primarily due to the high incidence of infectious and genetic diseases across the region. PCR-based diagnostics, a core component of NAAT, are widely recognized for their precision in detecting diseases with similar clinical symptoms or multiple causative pathogens. Consequently, the increasing disease burden is anticipated to further accelerate the adoption of NAAT technologies in North America.
For additional insights, refer to the latest highlights from the Nucleic Acid Amplification Testing Market Insights report - https://www.delveinsight.com/sample-request/nucleic-acid-amplification-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Recent Developments in the Nucleic Acid Amplification Testing Market
• In May 2024, bioMérieux entered into a strategic partnership with AnaBioTec, a leading analytical services provider supporting pharmaceutical, biopharmaceutical, and cell-based drug development. This collaboration aims to advance Mycoplasma testing standards within the biopharmaceutical and Cell & Gene Therapy sectors across Europe.
• In January 2021, Thermo Fisher Scientific Inc. completed the acquisition of Mesa Biotech, Inc. for USD 450 million. This acquisition strengthened Thermo Fisher's molecular diagnostics portfolio, particularly in PCR-based rapid point-of-care testing. Mesa Biotech is recognized for its innovations in PCR diagnostics for infectious diseases, enabling Thermo Fisher to enhance detection capabilities for pathogens such as SARS-CoV-2, Influenza A and B, RSV, and Strep A.
These strategic initiatives are expected to contribute significantly to the accelerated growth of the NAAT market over the forecast period.
Key Players in the Nucleic Acid Amplification Testing Market
Major companies operating in the NAAT market include Abbott Laboratories, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Seegene Inc., QIAGEN, bioMérieux, BD, Hologic, Inc., SHERLOCK BIOSCIENCES, Siemens Healthineers AG, Illumina, Inc., Danaher Corporation, Grifols, Meridian Bioscience, Inc., QuidelOrtho Corporation, among others.
To explore which MedTech companies are poised to shape future market trends, access insights on Key Nucleic Acid Amplification Testing Companies - https://www.delveinsight.com/sample-request/nucleic-acid-amplification-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Analysis of the Nucleic Acid Amplification Testing Market Landscape
Leading market participants are increasingly investing in innovative diagnostic solutions to enhance drug development and infectious disease management. For instance, in March 2022, Thermo Fisher Scientific Inc. launched the Invitrogen Colorimetric ReadiLAMP Kit for SARS-CoV-2 detection. This advanced solution enables rapid and accurate pathogen identification-including SARS-CoV-2, measles, and influenza within five minutes. The enhanced master mix features high-performance enzymes and supports multiple testing formats, offering greater flexibility across varying RNA and DNA concentrations.
Despite ongoing technological advancements, factors such as the risk of false-positive or false-negative outcomes and the technical complexity of NAAT procedures may pose challenges to market growth.
Scope of the Nucleic Acid Amplification Testing Market Report
• Geographical Coverage: Global
• Study Period: 2022-2032
• Segmentation by Product Type: Instruments; Reagents & Kits
• Segmentation by Technology: Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Transcription-Mediated Amplification (TMA), CRISPR, and Others
• Segmentation by Application: Infectious Disease Testing, Genetic Testing, Oncology Testing, and Others
• Segmentation by End User: Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutions, and Others
• Segmentation by Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Companies Covered: Abbott Laboratories, Agilent Technologies, Thermo Fisher Scientific, Roche, Merck & Co., PerkinElmer, Sysmex, Bio-Rad, Seegene, QIAGEN, bioMérieux, BD, Hologic, SHERLOCK BIOSCIENCES, Siemens Healthineers, Illumina, Danaher, Grifols, Meridian Bioscience, QuidelOrtho Corporation, and others
• Additional Analysis: Porter's Five Forces Analysis, Product Profiles, Case Studies, Key Opinion Leader (KOL) Insights, and Analyst Perspectives
To learn how the Nucleic Acid Amplification Testing market is expected to evolve by 2032, access a snapshot of the Nucleic Acid Amplification Testing Market Analysis - https://www.delveinsight.com/sample-request/nucleic-acid-amplification-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Nucleic Acid Amplification Testing Market Forecast 2025-2032: 8.13% CAGR Fueled by R&D and Diagnostics Innovation, estimates DelveInsight here
News-ID: 4319847 • Views: …
More Releases from DelveInsight Business Research
Limbal Stem Cell Deficiency Market to Surpass USD 2.6 Billion by 2034, Driven by …
In 2023, the Limbal Stem Cell Deficiency (LSCD) market was dominated by the United States, generating nearly USD 1.5 billion in revenue, while Spain represented the smallest market with approximately USD 127 million. This regional distribution is expected to remain consistent throughout the forecast timeline. The US accounted for nearly 103,000 diagnosed LSCD cases, whereas Japan recorded around 37,000 cases, with both countries projected to witness notable growth in patient…
SSc-ILD Market Set to Cross USD 750 Million by 2034, Driven by 10+ Emerging Ther …
The major players operating in the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market include Roche, Prometheus Biosciences, Inc., Merck, GlaxoSmithKline, Genentech, Inc., Acceleron, Boehringer Ingelheim, Actelion, Hôpital Claude-Huriez, Changchun GeneScience Pharmaceutical, among others.
DelveInsight's report titled "Systemic Sclerosis-associated Interstitial Lung Disease Market Insights, Epidemiology, and Forecast-2034" delivers a comprehensive analysis of SSc-ILD, covering historical data, projected epidemiology, and evolving market trends across the United States, EU4 (Germany, Spain, Italy, and France),…
Developmental and Epileptic Encephalopathy Treatment Market Poised for Accelerat …
The Developmental and Epileptic Encephalopathy (DEE) treatment market across the seven major markets (7MM) was valued at nearly USD 2.1 billion in 2023 and is expected to register a healthy compound annual growth rate over the forecast period. The United States emerged as the largest contributor, capturing close to 80% of the overall market revenue.
The DEE treatment landscape is undergoing a significant transformation as the limitations of traditional antiepileptic drugs…
Polycythemia Vera Pipeline and Drug Development in 2025: 10+ Therapies and 8+ Co …
DelveInsight's "Polycythemia Vera Pipeline Insight 2025" report delivers an in-depth overview of the Polycythemia Vera pipeline landscape, covering more than 8 companies and 10+ pipeline candidates. The report analyzes both clinical-stage and preclinical assets, offering detailed drug profiles across various stages of development. It also evaluates Polycythemia Vera therapies based on product classification, development stage, route of administration, and molecular category, while additionally spotlighting inactive or discontinued pipeline assets.
Explore the…
More Releases for Amplification
Guest Post: Rolling Circle Amplification Market
Introduction
Rolling Circle Amplification (RCA) is a highly efficient and versatile DNA amplification technique that has gained significant attention in recent years for its potential applications in biotechnology, molecular biology, diagnostics, and nanotechnology. Unlike traditional PCR (Polymerase Chain Reaction), RCA amplifies circular DNA templates through a process where a DNA polymerase synthesizes a long strand of DNA by continuously rolling around the template. This method produces multiple copies of the target…
Rolling Circle Amplification Market: Insights and Trends
Rolling Circle Amplification (RCA) is a novel DNA amplification technique that has gained significant attention in recent years. It is a versatile and efficient method for amplifying circular DNA sequences, and it has found applications in various fields, including molecular diagnostics, biotechnology, and medical research. RCA involves the use of a short DNA primer to initiate the synthesis of long single-stranded DNA products by rolling circle replication. This technique is…
Gene Amplification Technologies Market Size Report 2028
From 2021 to 2028, the global Gene Amplification Technologies Market is predicted to grow at a CAGR of 8.6%, from US$ 26,489 Million in 2020 to US$ 50,636 Million by 2028.
The global gene amplification technologies market is expected to exhibit strong growth during the forecast period, driven by the rising demand for COVID-19 testing and cancer research. This analysis provides comprehensive insights into market size, trends, drivers, challenges, regional outlook,…
Gene Amplification Technologies Market Report 2028
The Gene Amplification Technologies Market Research Report provides an in-depth analysis of the market dynamics, key players, and competitive landscape of the Gene Amplification Technologies industry. It aims to provide valuable insights into the market trends, growth opportunities, and challenges faced by the industry stakeholders. The report serves as a comprehensive guide for businesses and investors looking to make informed decisions in the Gene Amplification Technologies business.
The Gene Amplification Technologies…
Gene Amplification Technologies Market Size, CAGR | Growth - 2028
According to Ameco Research, the worldwide market for gene amplification technologies will increase at a CAGR of more than 8% throughout the forecast period, reaching a market size of more than US$ 50,630 million by 2028.
According to the World Cancer Research Fund, the worldwide toll of cancer cases was more than 18 million in 2020. Out of these, more than 9 million cases were in men and more than…
Whole Genome Amplification Market Investment Analysis
The whole genome amplification market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 6.90% in the forecast period of 2021 to 2028 and is expected to reach USD 4,492.52 million by 2028. The high application of the method in the various fields of the biological fields is escalating the growth…
